en
svPress releases
Regulatory press release 2026-08-05
Xspray Pharma Interim Report Second Quarter 2026
Press release 2026-06-26
Xspray Pharma provides regulatory update on its US product candidates Nilopki® and Dasynoc® and notes continued progress with its third-party manufacturer NerPharMa
Press release 2026-06-05
Xspray Pharma to host a conference call regarding Nilopki™
Regulatory press release 2026-06-04
Xspray Pharma Receives CRL from U.S. FDA for Nilopki™
Press release 2026-06-03
Xspray Pharma employees fully participate in market priced long term incentive programs, signaling strong confidence ahead
-
Latest report
Interim Report Q2 2026 -
Subscribe
Get our latest press releases and reports